Design Therapeutics, Inc. (DSGN) Debt Components
- 2021-06-30: Debt Instrument, Interest Rate, Stated Percentagepure 8.00%.
- 2021-03-31: Debt Instrument, Interest Rate, Stated Percentagepure 8.00%.
- 2019-02-28: Debt Instrument, Interest Rate, Stated Percentagepure 8.00%.
- 2018-07-31: Debt Instrument, Interest Rate, Stated Percentagepure 8.00%.
Design Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|
| 2021-06-30 | 8.00% |
| 2021-03-31 | 8.00% |
| 2019-02-28 | 8.00% |
| 2018-07-31 | 8.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |